Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and Urtoxazumab: Difference between pages
(Difference between pages)
Content deleted Content added
Saving copy of the {{drugbox}} taken from revid 466156572 of page Urtoxazumab for the Chem/Drugbox validation project (updated: 'CAS_number'). |
Entranced98 (talk | contribs) Adding local short description: "Monoclonal antibody", overriding Wikidata description "chemical compound" |
||
| Line 1: | Line 1: | ||
| ⚫ | |||
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid [{{fullurl:Urtoxazumab|oldid=466156572}} 466156572] of page [[Urtoxazumab]] with values updated to verified values.}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
| Verifiedfields = changed |
||
| Watchedfields = changed |
|||
| verifiedrevid = |
| verifiedrevid = 470620672 |
||
| image = |
| image = |
||
<!-- Monoclonal antibody data --> |
|||
| ⚫ | |||
| type = mab |
| type = mab |
||
| mab_type = mab |
| mab_type = mab |
||
| source = zu/o |
| source = zu/o |
||
| target = ''[[E. coli]]'' [[Shiga-like toxin]] II B subunit |
| target = ''[[E. coli]]'' [[Shiga-like toxin]] II B subunit |
||
| ⚫ | |||
| ⚫ | |||
| tradename = |
| tradename = |
||
| pregnancy_AU = |
| pregnancy_AU = |
||
| Line 22: | Line 21: | ||
| legal_status = |
| legal_status = |
||
| routes_of_administration = |
| routes_of_administration = |
||
| ⚫ | |||
| ⚫ | |||
| bioavailability = |
| bioavailability = |
||
| protein_bound = |
| protein_bound = |
||
| Line 29: | Line 27: | ||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| ⚫ | |||
| UNII = 232D35B3NT |
|||
| ATC_prefix = none |
| ATC_prefix = none |
||
| ATC_suffix = |
| ATC_suffix = |
||
| Line 39: | Line 38: | ||
| DrugBank = |
| DrugBank = |
||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
||
| ChemSpiderID = |
| ChemSpiderID = none |
||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| molecular_weight = 144.6 [[kDa]] |
|||
}} |
}} |
||
'''Urtoxazumab''' is a [[humanized monoclonal antibody]] against [[diarrhoea]] caused by ''[[Escherichia coli]]'', serotype [[Escherichia coli O121|O121]]. The drug is designed to bind to a [[toxin]] of this bacterium, so that it can be more easily broken down and eliminated from the body.<ref>{{cite web | url = http://whqlibdoc.who.int/druginfo/18_1_2004_INN.pdf | title = International Nonproprietary Names for Pharmaceutical Substances (INN) | publisher = World Health Organization }}</ref><ref>{{cite journal | vauthors = López EL, Contrini MM, Glatstein E, González Ayala S, Santoro R, Allende D, Ezcurra G, Teplitz E, Koyama T, Matsumoto Y, Sato H, Sakai K, Hoshide S, Komoriya K, Morita T, Harning R, Brookman S | display-authors = 6 | title = Safety and pharmacokinetics of urtoxazumab, a humanized monoclonal antibody, against Shiga-like toxin 2 in healthy adults and in pediatric patients infected with Shiga-like toxin-producing Escherichia coli | journal = Antimicrobial Agents and Chemotherapy | volume = 54 | issue = 1 | pages = 239–43 | date = January 2010 | pmid = 19822704 | pmc = 2798559 | doi = 10.1128/AAC.00343-09 }}</ref> |
|||
== References == |
|||
{{reflist}} |
|||
{{Monoclonals for infectious disease and toxins}} |
|||
[[Category:Monoclonal antibodies]] |
|||
[[Category:Experimental drugs]] |
|||
{{antiinfective-drug-stub}} |
|||
{{monoclonal-antibody-stub}} |
|||